Content related to A Simple Plasma-Based Biomarker Could Predict Liver Fibrosis in Latino Adolescents With Obesity

A CHLA expert explains the symptoms, causes and treatments for nonalcoholic fatty liver disease in children

The Southern California Center for Latino Health tackles health disparities in children to prevent the development of chronic diseases in adults.

Dr. Bhattacharjee is investigating potential therapies for the most severe form of fatty liver disease: metabolic dysfunction-associated steatohepatitis.

Children’s Hospital Los Angeles dedicates annual research symposium events to childhood obesity as a driver of chronic lifetime health issues including diabetes, heart disease and liver disease.

A new class of drugs can relieve itching for cholestatic childhood liver disease and potentially lengthen time until a liver transplant is necessary.

Children’s Hospital Los Angeles researchers develop app to predict if children with acute liver failure will need an urgent liver transplant or can recover on their own.

Clinical Research Coordinator Sirikorn Boonsawat explored careers in pharmacy and law before finding her niche working with Dr. Rohit Kohli at CHLA.

New clinical practice update advises on intestinal ultrasound use in treating Crohn’s disease and ulcerative colitis.

The Center is one of 11 centers funded by the National Institute on Minority Health and Health Disparities to address health disparities in multiple chronic diseases.